Cytori Therapeutics, Inc. (NASDAQ: CYTX) today announced that its Chief Executive Officer, Mr. Christopher Calhoun, will present at Noble Financial Capital Markets’ BIOX Life Sciences Exposition to be held at the University of Connecticut, Stamford Campus on September 24 at 9:30 AM ET.
In addition to the corporate presentation, Mr. Calhoun will be a participant on the panel presentation titled
Advancements in Cell Therapy & Regenerative Medicine,
September 24 at 11:45 AM ET.
Following the conference, a high-definition video webcast of Cytori’s presentation and the
Advancements in Cell Therapy & Regenerative Medicine
panel will be available on the
Cytori's web site
, or through the Noble Financial websites:
. You will need Microsoft SilverLight viewer (a free download from the presentation link) to participate. The webcast will be archived under “Webcasts” in the
Investor Relations section
of the Company’s website for 90 days.
Cytori Therapeutics, Inc. is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Our scientific data suggest ADRCs improve blood flow, moderate the immune response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple "ischemic" conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori's proprietary technologies and products, including the Celution® system product family.
About Noble Financial
Noble Financial Capital Markets was established in 1984 and is an equity research driven, full-service, investment banking boutique focused on life sciences, technology and media, emerging growth, companies. The company has offices in New York, Boston, New Jersey, Los Angeles, and Boca Raton, FL. In addition to non-deal road shows and sector-specific conferences throughout the year, Noble Financial hosts its large format annual equity conference in January in South Florida featuring 150 presenting companies from across North America and total attendance of close to 600. For more information: